JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 23, 2004; DOI: 10.1124/jpet.104.074823


0022-3565/05/3122-627-634$20.00
JPET 312:627-634, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.074823v1
312/2/627    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monneret, G.
Right arrow Articles by Powell, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monneret, G.
Right arrow Articles by Powell, W. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

INFLAMMATION AND IMMUNOPHARMACOLOGY

Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils

Guillaume Monneret, Radhia Boumiza, Sylvie Gravel, Chantal Cossette, Jacques Bienvenu, Joshua Rokach, and William S. Powell

Immunology Laboratory, Lyon-Sud University Hospital, Pierre-Bénite Lyon, France (G.M., R.B., J.B.); Meakins-Christie Laboratories, Department of Medicine, McGill University, Montreal, Quebec, Canada (S.G., C.C., W.S.P.); and Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology, Melbourne, Florida (J.R.)

Basophils are important in allergic diseases such as asthma because they produce a variety of inflammatory mediators. Activation of these cells with IgE and N-formyl-methionyl-leucyl-phenylalanine results in a variety of responses, including increased surface expression of CD203c and CD11b and release of histamine. Although considerable information is available on the effects of eicosanoids on neutrophils, eosinophils, and monocytes, less is known about their effects on basophils. In the present study, we examined the effects of various eicosanoids on the above basophil responses. Of the naturally occurring eicosanoids tested, prostaglandin D2 (PGD2; EC50, 10 nM) was by far the most potent activator of CD203c expression, with other prostanoids having little effect. This response was mediated by the DP2 receptor/chemoattractant receptor-homologous molecule expressed on Th2 cells because it was shared by the selective agonist 15R-methyl-PGD2 (EC50, 3 nM). The 5-lipoxygenase products leuko-triene B4 and 5-oxo-6,8,11,14-eicosatetraenoic acid also stimulated CD203c expression but to a lesser extent than PGD2, whereas leukotriene D4 was inactive. Neither PGD2 nor 5-oxo-6,8,11,14-eicosatetraenoic acid stimulated histamine release or CD63 expression on basophils. Both PGE2 and the DP1 receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] strongly inhibited DP2 receptor-mediated CD203c expression. The DP1 receptor antagonist BWA868C [3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidine-heptanoic acid] enhanced PGD2-induced CD203c expression, suggesting that interaction of PGD2 with DP1 receptors can limit activation of basophils by this prostaglandin. In conclusion, PGD2 is the most potent inducer of basophil CD203c expression among eicosanoids and may be a key mediator in asthma and other allergic diseases. The balance between DP1 and DP2 receptors may be important in determining the magnitude of basophil responses to this prostaglandin.


Received July 23, 2004; accepted September 23, 2004.

Address correspondence to: William S. Powell, Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montreal, Quebec, Canada H2X 2P2. E-mail: william.powell{at}mcgill.ca




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H. Sandig, J. E. Pease, and I. Sabroe
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function
J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Cossette, S. E. Walsh, S. Kim, G.-J. Lee, J. A. Lawson, S. Bellone, J. Rokach, and W. S. Powell
Agonist and Antagonist Effects of 15R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.